Department: Office of Research


Leadership is Service, Two Exceptional Leaders Advise University Leadership Academy

|

Fifteen faculty and staff members from the first cohort of the Health Sciences Senior Leadership Academy (HSSLA) at the University of Tennessee Health Science Center got a lesson last week from two extraordinary individuals who know a thing or two about leadership. At its first gathering January 13, the group was honored to welcome Randy Boyd, UT… Read More


Research Team Receives $1.5 Million to Study Neurological Disorders Linked to Long COVID

|
Jianyang Du

The National Institute of Mental Health has awarded a significant grant of $1.5 million to Jianyang Du, PhD, of the University of Tennessee Health Science Center, for a research study aimed at uncovering the cellular and molecular mechanisms that lead to neurological disorders caused by long COVID-19. Dr. Du is an associate professor at the… Read More


National Institute Awards $2.18 Million to Lebeche, Ishrat for Innovative Stroke Research

|

The National Institute of Neurological Disorders and Stroke has awarded $2.18 million to two researchers at the University of Tennessee Health Science Center for a project focused on a new drug treatment to protect the brain after a stroke. The principal investigators are Djamel Lebeche, PhD, professor in the Department of Physiology, and Tauheed Ishrat,… Read More


UT Research Foundation Honors Pioneers of Progress at 2024 Innovation Awards

|

UT Health Science Center researchers across the state were celebrated for their pioneering discoveries and entrepreneurial excellence at the 2024 University of Tennessee Research Foundation (UTRF) Innovation Awards. The ceremonies, held November 25 in Knoxville and December 4 in Memphis, honored the brilliant and dedicated faculty whose research-to-commercialization successes are driving real-world impact to treat… Read More


Dr. Kirk Hevener Awarded $3.7 Million for Groundbreaking Research on Bacterial Gut Infection Treatment

|

The National Institute of Allergy and Infectious Diseases has awarded $3.7 million to Kirk Hevener, PharmD, PhD, associate professor in the Department of Pharmaceutical Sciences at the University of Tennessee Health Science Center College of Pharmacy, for a project to develop new treatments for Clostridioides difficile (C. diff) infection, a serious and often deadly bacterial infection of… Read More


Balancing Bold Ideas and Financial Challenges: Dr. Amali Samarasinghe’s Resilient Journey to Success

|

Amali Samarasinghe, PhD, associate professor in the Department of Pediatrics at UT Health Science Center, describes herself as an aficionada of the alternative hypothesis. “I have a passion to uncover the inner workings of non-dogmatic possibilities.” Dr. Samarasinghe is the lead author of a comprehensive review on eosinophils published in the September 2024 edition of The… Read More


Jancelewicz Co-Principal Investigator on $11.4 Million Clinical Trial Grant to Study Treatment of Critically Ill Newborns

|

Tim Jancelewicz, MD, MA, MS, professor and interim chief of the Division of Pediatric Surgery at the University of Tennessee Health Science Center and Le Bonheur Children’s Hospital, is a co-principal investigator on an $11.4 million, multi-institutional clinical trial grant to study the efficacy of the longstanding practice of using nitric oxide to treat newborns… Read More


Dr. Brendan Tunstall Gains National Support for Opioid Dependence Research

|

Brendan Tunstall, PhD, assistant professor of pharmacology in the College of Graduate Health Sciences at the University of Tennessee Health Science Center, was recently awarded $423,500 from the National Institute on Drug Abuse for his exploration of a new approach to treat opioid dependence, a pressing global health issue. Dr. Tunstall, the sole principal investigator… Read More